Sunshine Biopharma (SBFMW) Acquisitions (2018)
Sunshine Biopharma (SBFMW) reported Acquisitions of $9884.0 for Q4 2018, up 111.6% quarter-over-quarter from -$85231.0 in Q3 2018.
Sunshine Biopharma (SBFMW) Acquisitions (2018) Analysis & Trends
Sunshine Biopharma has reported Acquisitions for 1 years, with the latest figure at $9884.0 in Q4 2018.
- For the quarter ending Q4 2018, Acquisitions changed N/A year-over-year to $9884.0; the trailing twelve-month figure through Sep 2019 stood at $9884.0 (up 300.0% YoY), and the FY2022 full-year result was $14.3 million, changed N/A from the prior year.
- Acquisitions for Q4 2018 stood at $9884.0, up from -$85231.0 in the prior quarter.
- The five-year high for Acquisitions was $80289.0 in Q1 2018, with the low at -$85231.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 2.09 Bn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | - |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | - |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 9,884.00 |
| Sep 30, 2018 | -85,231.00 |
| Mar 31, 2018 | 80,289.00 |